Palonosetron Exhibits Unique Molecular Interactions with the 5-HT3 Receptor

Camilo Rojas, Marigo Stathis, Ajit Thomas, +8

Anesthesia & Analgesia

Palonosetron triggers 5-HT3 receptor internalization and causes prolonged inhibition of receptor function

Camilo Rojas, Ajit G. Thomas, Jesse Alt, +6

European Journal of Pharmacology

Molecular PhysiologySignal TransductionMedicineHormonal ReceptorPhysiology +5

Design, Synthesis, and Pharmacological Evaluation of Bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl Sulfide 3 (BPTES) Analogs as Glutaminase Inhibitors

Krupa H. Shukla, Dana Ferraris, Ajit G. Thomas, +11

Journal of Medicinal Chemistry

Pharmaceutical ScienceGlutaminase InhibitorsPharmacotherapyTruncated AnalogsPharmaceutical Chemistry +14

The Antiemetic 5-HT3 Receptor Antagonist Palonosetron Inhibits Substance P-Mediated Responses In Vitro and In Vivo

Camilo Rojas, Ying Li, Jie Zhang, +7

Journal of Pharmacology and Experimental Therapeutics

Regional brain distribution of translocator protein using [11C]DPA-713 PET in individuals infected with HIV

Jennifer M. Coughlin, Yuchuan Wang, Shuangchao Ma, +19

Journal of NeuroVirology

Translocator ProteinMedicineHuman RetrovirusImmunologyNeurology +5

Synthesis and Biological Evaluation of Low Molecular Weight Fluorescent Imaging Agents for the Prostate-Specific Membrane Antigen

Ying Chen, Mrudula Pullambhatla, Sangeeta Ray Banerjee, +6

Bioconjugate Chemistry

Cambinol, a Novel Inhibitor of Neutral Sphingomyelinase 2 Shows Neuroprotective Properties

Mariana Figuera-Losada, Marigo Stathis, Joelle M. Dorskind, +9

PLoS ONE

Novel InhibitorCell DeathPharmaceutical ChemistryShows Neuroprotective PropertiesNeuroinflammation +17

Inhibition of substance P-mediated responses in NG108-15 cells by netupitant and palonosetron exhibit synergistic effects

Marigo Stathis, Claudio Pietra, Camilo Rojas, +1

European Journal of Pharmacology

Ng108-15 CellsSignal TransductionSubstance P-mediated ResponsesMedicineNeurotransmitter +5

Current whole-body MRI applications in the neurofibromatoses

Shivani Ahlawat, Laura M. Fayad, Muhammad Shayan Khan, +149

Neurology

Rate of binding of various inhibitors at the dopamine transporter in vivo

Marigo Stathis, Ursula Scheffel, Sandra Lever, +3

Psychopharmacology

BiochemistryFunctional SelectivityDopamine TransporterMedicineNeurotransmitter +7